Skip to main content

Advertisement

Springer Nature is making Coronavirus research free. View research | View latest news | Sign up for updates

Figure 1 | BMC Cancer

Figure 1

From: Inhibition of DNA methyltransferase activity and expression by treatment with the pan-deacetylase inhibitor panobinostat in hepatocellular carcinoma cell lines

Figure 1

Panobinostat affects activity and expression of DNA methyltransferases in vitro . (A) Total DNMT activity was evaluated in HepG2 and Hep3B cells treated with 0.1 μM panobinostat for the indicated points in time. Results are the mean remaining DNMT activity ± relative error of three independent experiments and are expressed relative to values of untreated controls with a set value of 1.0 for each point in time. * P < 0.05 vs. untreated controls. (B) and (C) Quantitative RT-PCR analysis of expression of DNMTs in HepG2 (B) and Hep3B (C) cells after treatment with 0.1 μM panobinostat. Results were normalized to the GAPDH level of each sample and represent mean ± relative error of three independent experiments and are expressed relative to mRNA levels of untreated controls at each point in time using the set value 1.0.

Back to article page